IOL Chemicals and Pharmaceuticals Receives CEP for Paracetamol to Export in European Market Kumar Jeetendra | May 8, 2023 IOL Chemicals and Pharmaceuticals Limited (IOL), a leading manufacturer of pharmaceutical (APIs) and specialty chemicals, has received the European Directorate for the Quality of Medicines & HealthCare’s (EDQM) Certificate of Suitability (CEP) to export Paracetamol to the European Market. Paracetamol is utilised commonly in medication prescribed for pain relief and to treat fever. The certification …
Israeli researchers develop an effective drug to prevent muscle diseases Kumar Jeetendra | April 4, 2023 Statins are the most commonly used medication in lowering blood cholesterol, prescribed to tens of millions in the Western world. Statins act through inhibition of the enzyme HMG CoA reductase. Nearly 20% of statin users develop muscle symptoms (“statin myopathy”) including weakness and pain. In about 1%, this myopathy is severe and does not subside …
Alembic Pharma announces Brimonidine Tartrate Ophthalmic Solution USFDA Final Clearance Kumar Jeetendra | March 31, 2023 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Brimonidine Tartrate Ophthalmic Solution, 0.15%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Alphagan P Ophthalmic Solution, 0.15%, of AbbVie Inc. Brimonidine Tartrate …
Definition, types, and parameters affecting effective synthesis reactions Kumar Jeetendra | March 13, 2023 The synthesis reaction is the process of combining two chemicals to form a new one. As we’ll see in a bit with photosynthesis, synthesis reactions don’t always produce just one product. Whether it results in a single complicated product or several simpler ones, the phrase “combination” is an excellent mental shorthand for a synthesis reaction. …
Alembic Pharma announces Brexpiprazole tablets USFDA Tentative Approval Kumar Jeetendra | March 10, 2023 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), …
Soft gelatine capsule temperature regulation: All you need to know Kumar Jeetendra | March 10, 2023 A solid oral dosage form, capsules are used for the delivery of life-saving medications, minerals, vitamins, and other healthful elements that are found in dietary supplements. These user-friendly containers make accurate dosing, mobility, and a high degree of consumer compliance possible. Other options include formulations that are more difficult to transport, such as liquid, powder, …
Alembic Pharmaceuticals announces USFDA Final Approval for Fluorouracil Injection USP Kumar Jeetendra | March 6, 2023 Alembic Pharmaceuticals Limited (Alembic) today announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial. The approved ANDA is therapeutically equivalent to the Reference Listed drug product (RLD), Fluorouracil Injection, 2.5 g/50 mL (50 …
Pharmaceutical Roots: Guaifenesin – a gift from the ‘Tree of Life’ Kumar Jeetendra | March 2, 2023 Pharmaceutical Roots is a content series from LGC Mikromol investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Introduction Worth close to $100 million in sales each year, and a staple ingredient in some of the world’s most trusted medicines for many …
Alembic Pharmaceuticals announces USFDA Final Approval for Docetaxel Injection USP Kumar Jeetendra | March 1, 2023 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Docetaxel Injection USP, 20 mg/2 mL (10 mg/mL) Single-Dose Vial, and 80 mg/8 mL (10 mg/mL) and 160 mg/16 mL (10 mg/mL) Multiple-Dose Vials. The approved ANDA is therapeutically …
Is it safe to take omnicef while pregnant? Kumar Jeetendra | March 1, 2023 Omnicef, also known as cefdinir, is a cephalosporin antibiotic that is utilised in the treatment of a wide variety of bacterial illnesses. In the United States, the Omnicef brand name has been taken off the market. There is a generic version of Omnicef that can be purchased. Cefdinir is an extended-spectrum, semisynthetic cephalosporin that can …
CIPLA launches CIPPOINT, a point-of-care gadget for non-communicable, infectious, and other disorders. Kumar Jeetendra | January 20, 2023 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced the launch of Cippoint, a point-of-care testing device. This state-of-the-art device offers a wide range of testing parameters including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. The device is CE IVD approved – …
Alembic Pharmaceuticals gets USFDA tentative approval for 100 mg Acalabrutinib capsules. Kumar Jeetendra | January 20, 2023 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Acalabrutinib Capsules, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Calquence Capsules, 100 mg, of AstraZeneca UK Limited (AstraZeneca). Acalabrutinib Capsules are …
